Seraphina Therapeutics Hits Significant Regulatory Milestone, Earning GRAS Status for FA15™

SAN DIEGO–(BUSINESS WIRE)– #C150–Seraphina Therapeutics, Inc., a health and wellness company dedicated to advancing global health through the discovery and development of beneficial essential fatty acids and micronutrients, today announced that it has achieved Generally Recognized as Safe (GRAS) status for its revolutionary FA15™ ingredient. FA15™ has been approved as a food ingredient that can be used daily, up to 245 mg per day. This includes consumption of FA15™ as an ingredient or fortifier in p
Click here to view original post